159 related articles for article (PubMed ID: 36009050)
1. Prediction of Potential Commercially Available Inhibitors against SARS-CoV-2 by Multi-Task Deep Learning Model.
Hu F; Jiang J; Yin P
Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36009050
[TBL] [Abstract][Full Text] [Related]
2. A deep learning method for repurposing antiviral drugs against new viruses via multi-view nonnegative matrix factorization and its application to SARS-CoV-2.
Su X; Hu L; You Z; Hu P; Wang L; Zhao B
Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34965582
[TBL] [Abstract][Full Text] [Related]
3. Computational investigation of drug bank compounds against 3C-like protease (3CL
Joshi T; Sharma P; Mathpal S; Joshi T; Maiti P; Nand M; Pande V; Chandra S
Mol Divers; 2022 Aug; 26(4):2243-2256. PubMed ID: 34637068
[TBL] [Abstract][Full Text] [Related]
4. A transferable deep learning approach to fast screen potential antiviral drugs against SARS-CoV-2.
Wang S; Sun Q; Xu Y; Pei J; Lai L
Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34081143
[TBL] [Abstract][Full Text] [Related]
5. A multi-stage virtual screening of FDA-approved drugs reveals potential inhibitors of SARS-CoV-2 main protease.
Mandour YM; Zlotos DP; Alaraby Salem M
J Biomol Struct Dyn; 2022 Mar; 40(5):2327-2338. PubMed ID: 33094680
[TBL] [Abstract][Full Text] [Related]
6. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.
Kumar Y; Singh H; Patel CN
J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274
[TBL] [Abstract][Full Text] [Related]
7. De novo design of novel protease inhibitor candidates in the treatment of SARS-CoV-2 using deep learning, docking, and molecular dynamic simulations.
Arshia AH; Shadravan S; Solhjoo A; Sakhteman A; Sami A
Comput Biol Med; 2021 Dec; 139():104967. PubMed ID: 34739968
[TBL] [Abstract][Full Text] [Related]
8. Synthetic flavonoids as potential antiviral agents against SARS-CoV-2 main protease.
Batool F; Mughal EU; Zia K; Sadiq A; Naeem N; Javid A; Ul-Haq Z; Saeed M
J Biomol Struct Dyn; 2022 May; 40(8):3777-3788. PubMed ID: 33251983
[TBL] [Abstract][Full Text] [Related]
9. Structure-based virtual screening, in silico docking, ADME properties prediction and molecular dynamics studies for the identification of potential inhibitors against SARS-CoV-2 M
Mohan A; Rendine N; Mohammed MKS; Jeeva A; Ji HF; Talluri VR
Mol Divers; 2022 Jun; 26(3):1645-1661. PubMed ID: 34480682
[TBL] [Abstract][Full Text] [Related]
10. Predictive modeling by deep learning, virtual screening and molecular dynamics study of natural compounds against SARS-CoV-2 main protease.
Joshi T; Joshi T; Pundir H; Sharma P; Mathpal S; Chandra S
J Biomol Struct Dyn; 2021 Oct; 39(17):6728-6746. PubMed ID: 32752947
[TBL] [Abstract][Full Text] [Related]
11. In silico analysis and identification of antiviral coumarin derivatives against 3-chymotrypsin-like main protease of the novel coronavirus SARS-CoV-2.
Abdizadeh R; Hadizadeh F; Abdizadeh T
Mol Divers; 2022 Apr; 26(2):1053-1076. PubMed ID: 34213728
[TBL] [Abstract][Full Text] [Related]
12. Identifying SARS-CoV-2 main protease inhibitors by applying the computer screening of a large database of molecules.
Sepehri B; Ghavami R; Mahmoudi F; Irani M; Ahmadi R; Moradi D
SAR QSAR Environ Res; 2022 May; 33(5):341-356. PubMed ID: 35502579
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the effects of chlorhexidine and several flavonoids as antiviral purposes on SARS-CoV-2 main protease: molecular docking, molecular dynamics simulation studies.
Tatar G; Salmanli M; Dogru Y; Tuzuner T
J Biomol Struct Dyn; 2022 Oct; 40(17):7656-7665. PubMed ID: 33749547
[TBL] [Abstract][Full Text] [Related]
14. Identification of potential antivirals against 3CLpro enzyme for the treatment of SARS-CoV-2: A multi-step virtual screening study.
Kumar V; Kar S; De P; Roy K; Leszczynski J
SAR QSAR Environ Res; 2022 May; 33(5):357-386. PubMed ID: 35380087
[TBL] [Abstract][Full Text] [Related]
15.
Chandra A; Chaudhary M; Qamar I; Singh N; Nain V
J Biomol Struct Dyn; 2022 Sep; 40(14):6534-6544. PubMed ID: 33583328
[TBL] [Abstract][Full Text] [Related]
16. In silico Study to Evaluate the Antiviral Activity of Novel Structures against 3C-like Protease of Novel Coronavirus (COVID-19) and SARS-CoV.
Chunduru K; Sankhe R; Begum F; Sodum N; Kumar N; Kishore A; Shenoy RR; Rao CM; Saravu K
Med Chem; 2021; 17(4):380-395. PubMed ID: 32720605
[TBL] [Abstract][Full Text] [Related]
17. Design of SARS-CoV-2 Mpro, PLpro dual-target inhibitors based on deep reinforcement learning and virtual screening.
Zhang LC; Zhao HL; Liu J; He L; Yu RL; Kang CM
Future Med Chem; 2022 Mar; 14(6):393-405. PubMed ID: 35220726
[No Abstract] [Full Text] [Related]
18. Structure-activity relationship (SAR) and molecular dynamics study of withaferin-A fragment derivatives as potential therapeutic lead against main protease (M
Ghosh A; Chakraborty M; Chandra A; Alam MP
J Mol Model; 2021 Feb; 27(3):97. PubMed ID: 33641023
[TBL] [Abstract][Full Text] [Related]
19. In Silico Evaluation of the Effectivity of Approved Protease Inhibitors against the Main Protease of the Novel SARS-CoV-2 Virus.
Eleftheriou P; Amanatidou D; Petrou A; Geronikaki A
Molecules; 2020 May; 25(11):. PubMed ID: 32485894
[TBL] [Abstract][Full Text] [Related]
20. In Silico Virtual Screening of Marine Aldehyde Derivatives from Seaweeds against SARS-CoV-2.
Kang N; Heo SY; Cha SH; Ahn G; Heo SJ
Mar Drugs; 2022 Jun; 20(6):. PubMed ID: 35736202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
